Advanced Manufacturing Cell for Hypochlorous Acid Production Now Available

A Unique Hardware Design, Titanium Anode, Nickel Cathode & Heat-Treated Silicon Creates the Best HOCL Production Experience

The new HOCL-1 from The Mandalay Group is now available to order on hoclclean.com and begins arriving to customers next week.

HOCL-1 brings a whole new level of versatility and capability to Hypochlorous acid production and is the best way to experience the newly improved, innovative system design.

HOCL-1 produces up to 350 Gallons of HOCL daily.

HOCL KILLS CORONAVIRUS (COVID-19).

If you’re like most people, you’ve never heard of hypochlorous acid, despite the fact that it’s in your body – as in right now – fighting the good fight.

By that we mean the fight against infection, because it’s the substance your white blood cells produce to keep you healthy. Because of this, hypochlorous acid uses are increasing every day.

You might be surprised to learn that your immune system’s fighter, hypochlorous acid, is actually based on chlorine.

It’s so gentle that hypochlorous acid is FDA approved for use in wound care and eye care products and is also common in veterinary care.

It’s also used in agriculture, as a biocide for horses and in dental care. It can kill E. coli and salmonella on contact with no harmful residues, which makes it ideal for food applications.

Hypochlorous acid is FDA approved for use in produce preservation and USDA approved for organic crop production. There has been extensive research on the gentleness and efficacy of hypochlorous acid.

We have harnessed the power of hypochlorous acid with our novel production process utilizing our HOCL-1 manufacturing cell to produce a safe but powerful multi-purpose cleaner that’s just as effective as conventional cleaners but with no harmful chemicals, residues or fumes.

Hypochlorous acid, the active ingredient is produced naturally by the body to combat infection.
White blood cells release this natural oxidant to fight invading pathogens.

The hypochlorous acid produced by the human body’s immune system:

✓ Reacts readily with a variety of microbial sub-cellular compounds
✓ Interferes with their metabolic processes
✓ Kills individual bacterium exposed within milliseconds

Since HOCL is non-irritant and non-persistent it is ideal for handwashing, misting, fogging and sanitizing tunnels / gateways.

HOCL is made by passing low-voltage electricity through saltwater (Sodium Chloride) in the HOCL-1. Our manufacturing cell splits the Sodium ions (Catholyte) from the Chlorine ions (Anolyte-Hypochlorous acid).

Together we face a serious world health emergency. To help these turbulent times, we have decided to make available our company’s wealth of expertise and experience.

We have been manufacturing and exporting water treatment systems, biodiesel systems and other electrochemical systems to businesses worldwide for many years.

The serious global situation has led us to create a solution that can be of public value:

HOCL-1 | Hypochlorous Acid Manufacturing Cell

HOCL-1 features titanium anode (+), nickel cathode (-) and heat-treated silicon gaskets.

Output: Sodium based Hypochlorous acid
Adjustable pH: 2.2 – 7.0
ORP Range: +600 to -850 mV
Free Available Chlorine: Up to 700 ppm
Production: 350 Gallons of Hypochlorous acid daily
Power: 110VAC/60 Hz – 220VAC/50 Hz @30A

The HOCL-1 ships complete with an adaptable power supply for domestic and International operation.
$2,999.00 with FREE Priority Mail Shipping in U.S.A.

Due to Covid-19 restrictions foreign orders must pay for shipping.

FOR MORE INFORMATION – CONTACT:
The Mandalay Group, Inc. – Associate: Bruce Burke
hello@mandalay.group | www.hoclclean.com | +1 (727) 612-5775

FOR MORE INFORMATION – CONTACT:
The Mandalay Group, Inc. – Associate: Bruce Burke
558 Clearwater-Largo Road N. #1 Largo, FL 33770
hello@mandalay.group | www.hoclclean.com | +1 (727) 612-5775

We have been manufacturing and exporting water treatment systems, biodiesel systems and other electrochemical systems to businesses worldwide for many years.

This release was published on openPR.